Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 196
- Uncategorized
Deutschlands “fehlerbehafteter” Cannabisplan erfordert einen enormen politischen Willen, um erfolgreich zu sein
Trotz einiger schwerwiegender Fehler in ihrem Ansatz ist es unwahrscheinlich, dass die Europäische Kommission die Befugnis hat, Deutschlands Bestreben, einen Cannabismarkt für Erwachsene zu etablieren, zu stoppen, sagt ein führender internationaler Drogenexperte.
- Adult-Use
Germany’s ‘Error-Strewn’ Cannabis Plan Requires Immense Political Will To Succeed
DESPITE some serious flaws in its approach it is unlikely that the European Commission has the powers to halt Germany’s ambition to establish an adult-use cannabis market, says a leading international drug policy expert.
- Adult-Use
Optimism for cannabis legalization as Democrats claim the house in Pennsylvania
DEMOCRAT WIN Optimism for cannabis legalization as Democrats claim the house in Pennsylvania Marijuana Moment reports that Pennsylvania Democrats say that they’ve won enough seats to take control of the House after Tuesday’s election — a development that could have major implications for cannabis reform in the state.
- Adult-Use
Two US states vote to approve recreational cannabis
Missouri and Maryland have passed bills allowing adult-use cannabis, whilst a number of cities across the country have voted to end prosecutions for cannabis use.
- Pharmaceutical
European Cannabis Stocks Review: Jazz Pharma Scraps US Sativex Trial, & IM Cannabis Pulls Out Of Canada
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals for $7.2bn last year, raised its revenue guidance for the full year this week in its Q3 financial results.
- Cultivation
How will congressional election outcomes affect cannabis reform?
MIDTERM ELECTIONS How will congressional election outcomes affect cannabis reform?
- Press releases
Portuguese Health Authority Grants Clever Leaves EU-GMP Certification For Post-Harvest Cannabis Flower
PRESS RELEASE CLEVER Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its facility in Portugal has been granted EU-GMP certification by the Portuguese Health Authority (INFARMED, I.P.) to manufacture dried cannabis flower as an active pharmaceutical ingredient and as finished product.
- News
Clever Leaves granted EU-GMP certification for cannabis flower
The company has been authorised for the certification by the Portuguese health authority INFARMED, I.P.
- Adult-Use
Switzerland ‘Could Well Become The Next European Country After Germany To Legalise Recreational Cannabis’
AFTER announcing a new joint venture with Solumedics AG last week, allowing it to import and sell medical cannabis in Switzerland for the first time, we spoke to Astrasana‘s CEO Yves Antoniazzi about his plans for the next year, and why now is the ‘perfect’ time to expand into the cannabis industry.
- Adult-Use
New York cannabis will “unlock new levels of innovation, prosperity and joy”
Leafly’s CEO, Yoko Miyashita, opened last week’s Business of Cannabis: New York with her keynote speech.
- Adult-Use
Midterm results see cannabis MSO stocks climb
CLIMBING HIGHER Midterm results see cannabis MSO stocks climb Cannabis stocks in the US edged higher on Wednesday with Maryland and Missouri voting in favor of legalizing adult-use cannabis, reports Proactive Investors.
- Uncategorized
Akanda schließt die erste Lieferung von medizinischem Cannabis nach Deutschland ab
Akanda hat erklärt, dass es bereit ist, die legalen Märkte für den Gebrauch durch Erwachsene in Europa zu bedienen, sobald sie etabliert sind.
